$ADHC sitting at long term support, on bounce watchOTC:ADHC has pulled back to .0016 which is long term support. Was recently trading above .004, opportunity at this level for a reversal. With multiple catalysts expected in 2025, I've got this on radar for a bounce into the new year. by screech6911
ADHC Stockupon review divergence is seen indicating a change in trend adx is creating large waves, uptrend may follow buying pressure is slightly increasing retesting prior support may make small gains The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction. Long term indicators fully support a continuation of the trend.by Danny911073
KEEP AN EYE ON ADHCLong term indicators fully support a continuation of the trend. I could not identify any clear divergence in rsi combined with with price action. The 20 sma is headed towards a bullish crossover of the 200 sma. Mac D positive crossover. The new moon is coming on the 12th, I use the lunar cycle with every trade but it may not be in every description I post. Stock returns are, on average, 4 bps lower daily (about 5% annually) for the 15 days around the full moon than for the 15 days around the new moon. Using a 7-day window, stock returns are, on average, 6 bps lower daily (about 4% annually) on the full moon days than on the new moon days. The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction. Remember! getting into a trade just off of an indicator is guessing, watch for divergence to find clear shift in momentum and use sma indictors such a golden cross to find confirmation. Also look in the candle sticks at lower time frames to help identify support levels. by Danny911070
$GTHP Long(Picture perfect breakout + retest above) Couple things to point out; 1B authorized, 189M shares Outstanding. - Already selling in Indonesia, Turkey, Nigeria, Kenya, Bulgaria -Plans to begin distribution into China, India, Russia, Poland, Hungry -USA FDA approval is an 18 month+ project -Product is superior cancer detection; painless, non-invasive with instant results. Sensitivity is much higher then current forms of testing. Great long term play for a global company. GLTAL Longby jake66Updated 1
$ADHC Long Good play on a speculative migraine pain management device. Around 600 M shares outstanding with low float and virtually no debt. A small investment in $ADHC could yield exponential returns in a few short years. Market cap could exceed to over $1B+ with successful FDA and clinical studies then successful marketplace execution. Over $1 PPS is not unreasonable with this massive pain management market. Good luck to longs. Longby jake662